Limited Offer
Kendig and Wilmott’s Disorders of the Respiratory Tract in Children
- 10th Edition - August 21, 2023
- Editors: Andrew Bush, Robin R Deterding, Albert Li, Felix Ratjen, Peter Sly, Heather Zar, Robert W. Wilmott
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 8 2 9 1 5 - 1
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 2 9 1 6 - 8
Extensively revised from cover to cover, Kendig and Wilmott's Disorders of the Respiratory Tract in Children, 10th Edition, continues to be your #1 choice for reliable, up-to-date… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote-
Offers an international perspective on the whole spectrum of the specialty, including a robust video library with demonstrations of key procedures and bronchoscopic views.
-
Uses a consistent format with succinct, bulleted text, and contains abundant tables and figures, chapter summaries, and more than 500 full-color images to convey key information in an easy-to-digest manner.
-
Contains eleven new chapters and discusses timely topics such as big data and -omics in respiratory disease, COVID-19, obesity and its consequences, and vaping and nicotine addiction among children and young people.
-
Provides up-to-date instruction on key procedures, such as bronchoscopy and pulmonary function testing.
-
Highlights the knowledge and expertise of nearly 90 new authors who are global experts in the fields of pediatrics, pulmonology, neurology, microbiology, cardiology, physiology, diagnostic imaging, critical care, otolaryngology, allergy, and surgery.
-
An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.
pediatric pulmonologists (~1000, per ATS), pediatricians at all levels (92,000 in the US alone)
- Instructions for online access
- Cover image
- Title page
- Table of Contents
- Copyright
- List of Contributors
- Preface
- Section 1. Scientific Basis of Pediatric Pulmonology
- 1. Molecular and Cellular Determinants of Lung Morphogenesis
- Introduction
- Organogenesis of the Lung
- Molecular Mechanisms Directing Lung Development
- Development of the Pulmonary Host Defense Systems
- Gene Mutations in Lung Development and Function
- Summary
- 2. Basic Genetics and Epigenetics of Childhood Lung Disease
- INTRODUCTION
- TYPES OF GENETIC VARIATION
- TECHNOLOGIES TO IDENTIFY GENETIC VARIATION
- INTERPRETATION OF GENETIC VARIATION
- WHEN TO CONSIDER CLINICAL GENETIC TESTING
- RESEARCH STUDY DESIGNS TO ATTRIBUTE GENETIC VARIATION TO DISEASE
- EPIGENETICS—TERMINOLOGY AND TECHNOLOGY
- “MULTI-OMICS” APPROACHES TO REFINE GENOTYPE-PHENOTYPE ASSOCIATIONS
- 3. Big Data and Omics in Respiratory Diseases:: An Analytical Perspective
- INTRODUCTION
- THE OMICS REVOLUTION IN RESPIRATORY DISEASES
- BIG DATA ANALYTICS TO HARNESS MULTI-OMICS DATA
- CONCLUDING REMARKS
- 4. The Surfactant System
- SURFACTANT COMPOSITION AND METABOLISM
- SURFACTANT FUNCTION
- SURFACTANT DEFICIENCY
- SURFACTANT TREATMENT OF SURFACTANT DEFICIENCY
- 5. The Structural and Physiologic Basis of Respiratory Disease
- NORMAL LUNG ANATOMY AND CELL FUNCTION
- AIRWAYS
- ALVEOLAR REGION
- PULMONARY VASCULAR SYSTEM
- LYMPHATIC SYSTEM
- INNERVATION OF THE LUNG
- INTERSTITIUM
- GROWTH AND DEVELOPMENT OF THE LUNG
- THE LUNG AT BIRTH
- POSTNATAL LUNG GROWTH
- VENTILATION AND MECHANICS OF BREATHING
- DEFINITIONS AND SYMBOLS
- ELASTIC RECOIL OF THE LUNG
- COMPLIANCE OF THE LUNG
- ELASTIC PROPERTIES OF THE CHEST WALL
- LUNG VOLUMES
- REGIONAL LUNG VOLUMES
- DYNAMIC (FLOW-RESISTIVE) PROPERTIES OF THE LUNG
- DISTRIBUTION OF VENTILATION
- PULMONARY CIRCULATION
- PULMONARY VASCULAR PRESSURES
- PULMONARY VASCULAR RESISTANCE
- DISTRIBUTION OF BLOOD FLOW
- METHODS OF EVALUATING THE PULMONARY CIRCULATION
- Muscles of Respiration
- GAS EXCHANGE
- ALVEOLAR VENTILATION
- DEAD SPACE
- DIFFUSION
- SHUNT AND VENTILATION-PERFUSION RELATIONSHIPS
- SYSTEMIC GAS TRANSPORT
- OXYGEN THERAPY
- CARBON DIOXIDE TRANSPORT AND ACID-BASE BALANCE
- TISSUE RESPIRATION
- REGULATION OF RESPIRATION
- SENSORY FEEDBACK SYSTEM
- METABOLIC FUNCTIONS OF THE LUNG
- Acknowledgments
- 6. Biology and Assessment of Airway Inflammation
- INTRODUCTION
- ALLERGIC INFLAMMATION
- ACUTE INFLAMMATION
- CHRONIC INFLAMMATION
- INFLAMMATORY CELLS
- STRUCTURAL CELLS AS SOURCES OF MEDIATORS
- INFLAMMATORY MEDIATORS
- NEURAL MECHANISMS
- TRANSCRIPTION FACTORS
- ANTIINFLAMMATORY MECHANISMS
- DIRECT MEASUREMENTS OF AIRWAY INFLAMMATION
- NONINVASIVE ASSESSMENT OF AIRWAY INFLAMMATION
- IS AIRWAY HYPERRESPONSIVENESS AN INFLAMMATORY SURROGATE?
- OTHER POTENTIAL INDIRECT INFLAMMATORY MARKERS
- IS THERE A ROLE FOR ASSESSING INFLAMMATION IN PEDIATRIC RESPIRATORY DISEASE?
- THERAPEUTIC IMPLICATIONS
- CONCLUSION
- 7. Lung Defenses: Intrinsic, Innate, and Adaptive
- INTRINSIC LUNG DEFENSES
- INNATE LUNG DEFENSES
- CELLULAR DEFENSES: AT THE CROSSROADS OF INNATE AND ADAPTIVE IMMUNITY
- ADAPTIVE LUNG DEFENSES
- ROLE OF PROGRAMMED CELL DEATH IN LUNG GROWTH, INJURY, AND REPAIR
- SUMMARY
- Section 2. Clinical Tools of Pediatric Pulmonology
- 8. History, Physical Examination, and Strategies for Remote Monitoring
- THE PEDIATRIC RESPIRATORY HISTORY
- THE PATIENT AND THEIR FAMILY
- 9. Bronchoscopy and Bronchoalveolar Lavage in Pediatric Patients
- THE SCOPE OF BRONCHOSCOPY
- INSTRUMENTATION
- INDICATIONS FOR BRONCHOSCOPY
- CONTRAINDICATIONS TO BRONCHOSCOPY
- TECHNIQUES FOR BRONCHOSCOPY
- ANESTHESIA FOR BRONCHOSCOPY
- BRONCHOALVEOLAR LAVAGE
- DIAGNOSTIC TECHNIQUES OTHER THAN BRONCHOALVEOLAR LAVAGE
- THERAPEUTIC BRONCHOSCOPY
- THERAPEUTIC ASPIRATION
- BRONCHOPLEURAL FISTULA—DIAGNOSIS AND MANAGEMENT
- COMPLICATIONS OF BRONCHOSCOPY
- ECONOMIC CONSIDERATIONS IN BRONCHOSCOPY
- 10. Diagnostic Imaging of the Respiratory Tract
- PLAIN RADIOGRAPHY
- SPECIFIC FEATURES OF THE CHEST RADIOGRAPH IN CHILDREN
- SYSTEMATIC REVIEW OF THE CHEST RADIOGRAPH
- FLUOROSCOPIC TECHNIQUES
- COMPUTED TOMOGRAPHY
- ISOTROPIC COMPUTED TOMOGRAPHY
- DATA PROCESSING
- REVIEW OF FINDINGS
- PITFALLS
- RADIATION DOSE
- THORACIC COMPUTED TOMOGRAPHY
- CONTROLLED VENTILATION TECHNIQUE
- TEAM WORKING IN PAEDIATRIC RESPIRATORY CT
- INTERPRETATION
- ANGIOGRAPHY
- MAGNETIC RESONANCE IMAGING
- ENDOBRONCHIAL ULTRASONOGRAPHY
- ULTRASONOGRAPHY
- RADIONUCLIDE IMAGING
- CONCLUSION
- 11. Pulmonary Function Tests in Infants and Preschool Children
- INTRODUCTION
- THE CHALLENGES ASSOCIATED WITH INFANT AND PRESCHOOL PULMONARY FUNCTION TESTS AND THE UNIQUE PHYSIOLOGY OF THE YOUNGEST POPULATION
- INFANT PULMONARY FUNCTION TEST TECHNIQUES
- INFANT PULMONARY FUNCTION TEST FINDINGS IN DISEASE
- PRESCHOOL PULMONARY FUNCTION TEST TECHNIQUES
- PRESCHOOL PULMONARY FUNCTION TEST FINDINGS IN DISEASE
- GAPS AND FUTURE DIRECTIONS
- 12. Exercise, Physical Activity, and Respiratory Health and Disease in Pediatrics
- THE BIOLOGICAL IMPORTANCE OF PHYSICAL ACTIVITY IN THE GROWING CHILD
- LABORATORY CARDIOPULMONARY EXERCISE TESTING WITH MEASUREMENT OF GAS EXCHANGE
- Nonlaboratory and Field Tests of Exercise Response and Fitness (See Table 12.2)
- THE NEED FOR INTEROPERABILITY, DATA SHARING, AND STANDARDS IN PEDIATRIC CRF TESTING
- ASTHMA AND EXERCISE
- AIR QUALITY AND EXERCISE
- PHYSICAL ACTIVITY AND EXERCISE IN CYSTIC FIBROSIS AND SICKLE CELL DISEASE
- EXERCISE-INDUCED LARYNGEAL OBSTRUCTION
- EXERCISE, COVID-19, AND LONG-TERM CONSEQUENCES OF SARS-CoV-2 INFECTION
- TOWARD THE FUTURE: PEDIATRIC EXERCISE SCIENCE IN THE AGE OF MOLECULAR MECHANISMS, DATA SCIENCE, AND SOCIAL DETERMINANTS OF HEALTH
- 13. Integrating Patient-Reported Outcomes Into Research and Clinical Practice: Measures of Health-Related Quality of Life and Mental Health
- DEFINITION OF A PATIENT-REPORTED OUTCOME
- DEVELOPMENT AND UTILIZATION OF PATIENT-REPORTED OUTCOMES
- DEVELOPMENTAL CONSIDERATIONS
- USE OF PROXY RESPONDENTS
- HEALTH-RELATED QUALITY-OF-LIFE MEASURES
- SCREENING FOR COMMON MENTAL HEALTH CONDITIONS
- PREVALENCE OF DEPRESSION AND ANXIETY IN ASTHMA
- PREVALENCE OF DEPRESSION AND ANXIETY IN CYSTIC FIBROSIS
- PREVALENCE OF DEPRESSION AND ANXIETY IN PRIMARY CILIARY DYSKINESIA
- RECOMMENDATIONS FOR MENTAL HEALTH SCREENING MEASURES
- REVIEW OF DISEASE-SPECIFIC RESPIRATORY HRQOL MEASURES FOR ASTHMA, CYSTIC FIBROSIS, AND PRIMARY CILIARY DYSKINESIA
- Clinical Utility of HRQoL and Mental Health Screening
- CONCLUSIONS AND FUTURE DIRECTIONS
- 14. Aerosol Therapy in Children
- INTRODUCTION
- BASIC PRINCIPLES OF AEROSOL THERAPY
- AEROSOL DELIVERY DEVICES
- MATCH THE DEVICE TO THE PATIENT
- INHALATION INSTRUCTIONS
- MONITORING ADHERENCE
- MAINTENANCE AND CLEANING INSTRUCTIONS
- AEROSOL THERAPY IN SPECIAL CIRCUMSTANCES
- IN CONCLUSION
- 15. Physical Therapies in Pediatric Respiratory Disease
- INTRODUCTION
- AIRWAY CLEARANCE
- RESPIRATORY PHYSIOTHERAPY FOR SPECIFIC CONDITIONS
- EXERCISE
- CONTINENCE
- INHALATION THERAPIES
- FREQUENCY AND DOSAGE
- ADHERENCE
- OTHER CONSIDERATIONS
- CONDITIONS NOT GENERALLY AMENABLE TO PHYSIOTHERAPY
- SUMMARY
- Appendix 1
- APPENDIX 2:
- 16. Children Dependent on Respiratory Support: Invasive and Non-Invasive Ventilation
- Introduction
- Epidemiology
- Goals of Therapy
- General Considerations for Home Care
- Treatment of Chronic Respiratory Failure
- Ancillary Equipment
- Patient Follow-up
- Outcomes
- Summary
- 17. Microbiological Diagnosis of Respiratory Illness
- RESPIRATORY PATHOGENS AND SYNDROMES
- USE OF THE CLINICAL MICROBIOLOGY LABORATORY
- MICROBIOME
- FUTURE PROSPECTS
- 18. Transition From Pediatric to Adult Care
- Introduction
- Transition: A Practical Approach
- Evidence for Transition
- Barriers to Transition
- Understanding Adolescent Development
- Preparing for Transition
- Meeting Needs of Adolescents During the Transition Period
- Preparing Adult Clinicians to Receive Adolescents and Young Adults With Chronic Respiratory Conditions
- Summary
- 19. Long-Term Consequences of Childhood Respiratory Disease
- INTRODUCTION
- HOW THE LUNG DEVELOPS IN HEALTH AND DISEASE
- EARLY LIFE ORIGINS OF ADULT DISEASE
- SUMMARY: WHAT HAVE WE LEARNED ABOUT THE IMPORTANCE OF ANTENATAL AND CHILDHOOD FACTORS?
- LONG-TERM CONSEQUENCES OF SPECIFIC DISEASES
- WHAT ARE THE PUBLIC HEALTH IMPLICATIONS?
- WHEN SHOULD WE MEASURE SPIROMETRY?
- SUMMARY AND CONCLUSIONS
- 20. Pediatric Lung Transplantation
- INTRODUCTION
- INDICATIONS AND TIMING
- CONTRAINDICATIONS
- SURGICAL TECHNIQUE
- POSTTRANSPLANT MANAGEMENT
- MANAGEMENT ISSUES UNIQUE TO PEDIATRICS
- COMPLICATIONS
- OUTCOMES
- FUTURE DIRECTIONS
- Section 3. Neonatal Pediatric Pulmonology
- 21. Congenital Lung Disease
- INTRODUCTION
- CLINICAL APPROACH
- THE SIZE OF THE PROBLEM: EPIDEMIOLOGY OF CONGENITAL MALFORMATIONS OF THE LUNG
- ANTENATAL DIAGNOSIS AND MANAGEMENT OF CONGENITAL LUNG DISEASE
- ANTENATAL DIAGNOSIS OF CONGENITAL LUNG LESIONS
- CONGENITAL ABNORMALITIES OF THE UPPER AIRWAY
- SPECIFIC PROBLEMS: CONGENITAL BRONCHIAL ABNORMALITIES
- SPECIFIC PROBLEMS: PARENCHYMAL LESIONS
- FOREGUT (BRONCHOGENIC) CYSTS (CLINICALLY, CYSTIC CONGENITAL THORACIC MALFORMATIONS)
- CONGENITAL LARGE HYPERLUCENT LOBE
- PREVENTION OF (NON-MALIGNANT) COMPLICATIONS
- OPTIMIZING LUNG GROWTH
- RELATIONSHIP BETWEEN CONGENITAL THORACIC MALFORMATIONS AND MALIGNANT TRANSFORMATION
- ADENOCARCINOMA AND CONGENITAL THORACIC MALFORMATIONS
- SUMMARY AND CONCLUSIONS: WHAT APPROACH IS BEST FOR AN ASYMPTOMATIC CONGENITAL THORACIC MALFORMATION?
- PULMONARY SEQUESTRATION
- SPECIFIC PROBLEMS: OVEREXPANSION, APLASIA AND ECTOPIA
- ECTOPIA
- SPECIFIC PROBLEMS: ABNORMAL CONNECTIONS BETWEEN THE BRONCHIAL TREE AND OTHER STRUCTURES
- OTHER ABNORMAL CONNECTIONS
- SPECIFIC PROBLEMS: CONGENITAL DISEASE OF THE PULMONARY ARTERIAL TREE
- SPECIFIC PROBLEMS: CONGENITAL DISEASE OF THE PULMONARY VENOUS TREE
- SPECIFIC PROBLEMS: ABNORMALITIES OF THE CONNECTIONS BETWEEN THE PULMONARY ARTERIAL AND VENOUS TREES
- SPECIFIC PROBLEMS: CONGENITAL DISEASE OF THE LYMPHATIC TREE
- SPECIFIC PROBLEMS: CONGENITAL DISORDERS OF THE CHEST WALL AND DIAPHRAGM
- SPECIFIC PROBLEMS: CONGENITAL CARDIAC DISORDERS
- SPECIFIC PROBLEMS: MULTISYSTEM CONGENITAL DISORDERS THAT AFFECT THE LUNG
- ROLE OF SPECIFIC INVESTIGATIONS
- SUMMARY AND CONCLUSIONS
- ACKNOWLEDGMENTS
- 22. Respiratory Disorders in the Newborn
- INITIATION OF RESPIRATION AT BIRTH
- FETAL LUNG FLUID
- RESPIRATORY DEPRESSION AT BIRTH
- DELIVERY ROOM RESUSCITATION
- VENTILATORY CONTROL
- RESPIRATORY DISTRESS SYNDROME
- TRANSIENT TACHYPNEA OF THE NEWBORN
- MECONIUM ASPIRATION SYNDROME
- ACUTE RESPIRATORY DISTRESS SYNDROME
- EARLY-ONSET PNEUMONIA
- LATE-ONSET PNEUMONIA
- ASPIRATION PNEUMONIA
- INTERSTITIAL LUNG DISEASE
- PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN
- PULMONARY HYPERTENSION IN BRONCHOPULMONARY DYSPLASIA
- PNEUMOTHORAX
- PNEUMOMEDIASTINUM
- PNEUMOPERICARDIUM
- PULMONARY INTERSTITIAL EMPHYSEMA
- SECONDARY PULMONARY HYPOPLASIA
- PATENT DUCTUS ARTERIOSUS
- PULMONARY EDEMA
- PULMONARY HEMORRHAGE
- UPPER AIRWAY OBSTRUCTION
- GASTROESOPHAGEAL REFLUX
- 23. Bronchopulmonary Dysplasia
- INTRODUCTION
- DISEASE DEFINITIONS
- EPIDEMIOLOGY
- ETIOLOGY
- PATHOGENESIS
- PATHOPHYSIOLOGY
- CLINICAL FEATURES
- PREVENTION
- TREATMENT
- PROGNOSIS
- SUMMARY
- Section 4. Respiratory Infections
- 24. Acute Infections That Produce Upper Airway Obstruction
- VIRAL LARYNGOTRACHEOBRONCHITIS
- DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
- EPIGLOTTITIS
- BACTERIAL TRACHEITIS
- DIPHTHERIA
- RETROPHARYNGEAL ABSCESS
- PERITONSILLAR ABSCESS (QUINSY)
- INFECTIOUS MONONUCLEOSIS
- 25. Bronchiolitis
- EPIDEMIOLOGY
- ETIOLOGY
- PATHOLOGY/PATHOGENESIS
- CLINICAL FEATURES
- DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
- MANAGEMENT AND TREATMENT
- PREVENTION
- PROGNOSIS
- 26. Pneumonia in Children
- EPIDEMIOLOGY AND ETIOLOGY
- PATHOGENESIS
- CLINICAL FEATURES
- ETIOLOGIC DIAGNOSIS
- DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
- GENERAL MANAGEMENT
- TREATMENT WITH ANTIMICROBIALS
- SLOWLY RESOLVING PNEUMONIA
- COMPLICATIONS
- PREVENTION
- PREVENTION BY VACCINES
- PROGNOSIS
- 27. New and Emerging Viral Infections of the Lung; Focus on SARS-CoV-2
- INTRODUCTION
- SURVEILLANCE
- SUMMARY OF HIGH-CONSEQUENCE INFECTIOUS DISEASES IN CHILDREN
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY
- TRANSMISSION
- CLINICAL PRESENTATION AND COMPLICATIONS
- DIAGNOSIS AND INVESTIGATIONS
- MANAGEMENT OF COVID-19
- MANAGEMENT OF MIS-C
- PREVENTION AND VACCINATION
- EMERGING VARIANTS OF COVID-19
- THE IMPACT OF COVID-19 ON ACUTE RESPIRATORY ILLNESS IN CHILDREN
- THE FUTURE OF RESPIRATORY INFECTIONS AND THE ENVIRONMENT
- 28. Tuberculosis
- EPIDEMIOLOGY
- MYCOBACTERIOLOGY
- IMMUNOLOGY
- PATHOPHYSIOLOGY
- CLINICAL FEATURES
- DIAGNOSIS
- TESTS OF INFECTION
- LABORATORY DIAGNOSIS
- TREATMENT
- CONTROL AND PREVENTION
- 29. Nontuberculous Mycobacterial Disease
- MICROBIOLOGY
- EPIDEMIOLOGY
- ACQUISITION AND POTENTIAL FOR TRANSMISSION
- CLINICAL MANIFESTATIONS OF NONTUBERCULOUS MYCOBACTERIA PULMONARY DISEASE
- DIAGNOSIS OF NONTUBERCULOUS MYCOBACTERIA PULMONARY DISEASE
- MANAGEMENT AND TREATMENT
- OUTCOMES
- 30. The Mycoses
- INTRODUCTION
- ANTIFUNGAL DRUGS
- ENDEMIC MYCOSES
- Pulmonary Mycoses Primarily Seen in Hosts With Impaired Immunity
- Acknowledgments
- 31. Pertussis and Other Bordetella Infections of the Respiratory Tract
- Epidemiology
- Etiology
- Pathology/Pathogenesis
- Clinical Features
- Imaging, Pulmonary Function Testing, Laboratory Findings
- Diagnosis and Differential Diagnosis
- Management and Treatment
- Prevention
- Prognosis
- 32. Toxocariasis, Hydatid Disease of the Lung, Strongyloidiasis, and Pulmonary Paragonimiasis
- Toxocariasis
- Echinococcosis (Hydatid Disease)
- Strongyloidiasis
- Pulmonary Paragonimiasis (Lung Fluke Disease)
- Section 5. Asthma and Other Wheezing Disorders
- 33. Epidemiology of Childhood Asthma
- INTRODUCTION
- ESTIMATES OF THE WORLDWIDE PREVALENCE OF ASTHMA
- GEOGRAPHICAL VARIATIONS IN THE PREVALENCE OF CHILDHOOD ASTHMA
- Conclusion
- 34. The Immunopathogenesis of Asthma
- Altered Pulmonary Immunity in Asthma Inception
- Cells, Molecules, and Cytokines Involved in Pediatric Allergic Asthma
- School-Age Allergic Asthma: Pathology and Mechanisms
- The Clinical Relevance of Eosinophilic Inflammation in School-Age Asthma
- Essential Role of Structural Airway Cells in Pulmonary Immunity and Asthma Pathogenesis
- Preschool Wheeze: A Unique Maturing Immune Environment
- Specific Clinical Scenarios for Consideration
- Summary
- 35. Asthma in the Preschool-Age Child
- EPIDEMIOLOGY AND BURDEN
- DIAGNOSIS
- Management
- NATURAL HISTORY
- 36. Wheezing in Older Children: Asthma
- INTRODUCTION
- PATHOLOGY
- PATHOPHYSIOLOGY
- NATURAL HISTORY AND PROGNOSIS
- DIAGNOSIS OF ASTHMA
- APPROACH TO MANAGEMENT
- 37. Severe Asthma
- INTRODUCTION
- OVERARCHING PRINCIPLES
- THE PREVALENCE OF SEVERE ASTHMA
- DEFINITIONS
- WHY IS ASTHMA CONTROL POOR?
- CLINICAL AND PATHOPHYSIOLOGICAL CHARACTERISTICS OF SEVERE ASTHMA
- SEVERE ASTHMA: FURTHER ASSESSMENTS
- MANAGEMENT OF SEVERE ASTHMA
- LOOKING AHEAD TO ADULT LIFE
- SUMMARY AND FUTURE DEVELOPMENTS
- Section 6. Cystic Fibrosis and Other Causes of Chronic Airway Infection
- 38. Genetics and Pathophysiology of Cystic Fibrosis
- INTRODUCTION
- CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE
- Cystic Fibrosis Transmembrane Conductance Regulator Protein
- Cellular Distribution and Function
- Tissue Distribution
- Genotype-Phenotype Correlations
- PATHOPHYSIOLOGY
- CHARACTERISTICS OF SYSTEMIC DISEASE
- 39. Diagnosis and Presentation of Cystic Fibrosis
- DIAGNOSTIC CRITERIA FOR CYSTIC FIBROSIS
- MAKING THE DIAGNOSIS OF CYSTIC FIBROSIS
- ANTENATAL TESTING FOR CYSTIC FIBROSIS
- NEONATAL SCREENING FOR CYSTIC FIBROSIS
- THE PHENOTYPIC SPECTRUM OF CYSTIC FIBROSIS—INFLUENCING FACTORS
- CYSTIC FIBROSIS PHENOTYPES
- 40. Pulmonary Disease in Cystic Fibrosis
- EPIDEMIOLOGY
- ETIOLOGY AND PATHOGENESIS
- CLINICAL FEATURES: SYMPTOMS AND PHYSICAL FINDINGS
- Monitoring Lung Disease
- MANAGEMENT AND TREATMENT
- AIRWAY HYDRATING AGENTS
- PROGNOSIS
- CONCLUSIONS
- 41. Nonpulmonary Manifestations of Cystic Fibrosis
- PANCREATIC DISEASE
- FIBROSING COLONOPATHY
- PANCREATITIS
- NUTRITION
- HEPATOBILIARY DISEASE
- GALLBLADDER DISEASE
- CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR AND THE INTESTINE
- GASTROESOPHAGEAL REFLUX DISEASE
- GASTROPARESIS
- SMALL INTESTINE DYSMOTILITY AND BACTERIAL OVERGROWTH
- CONSTIPATION
- RECTAL PROLAPSE
- GASTROINTESTINAL CANCERS
- INFERTILITY
- CYSTIC FIBROSIS-RELATED DIABETES
- CYSTIC FIBROSIS BONE DISEASE
- CONCLUSION
- 42. Modern Molecular Therapies for Cystic Fibrosis
- INTRODUCTION
- CFTR MODULATORS
- POTENTIATOR MONOTHERAPY
- MODULATOR COMBINATION THERAPIES
- OTHER DRUGS RESTORING CFTR FUNCTION: THE TRIALS PIPELINE
- NON-CFTR ION CHANNELS AS DRUG TARGETS
- CFTR GENE REPLACEMENT
- Gene Editing
- mRNA Editing
- Other RNA-Based Technologies
- REMAINING CHALLENGES AND OPPORTUNITIES IN THE DEVELOPMENT OF MOLECULAR THERAPIES FOR CYSTIC FIBROSIS
- CONCLUSIONS
- 43. Primary Ciliary Dyskinesia and Other Ciliopathies
- INTRODUCTION
- STRUCTURE AND FUNCTION OF CILIA
- CLINICAL FEATURES
- DIAGNOSIS
- GENETICS OF PRIMARY CILIARY DYSKINESIA
- ULTRASTRUCTURAL CILIARY DEFECTS
- NASAL NITRIC OXIDE MEASUREMENTS
- ASSESSMENT OF CILIARY FUNCTION
- MANAGEMENT AND TREATMENT
- PROGNOSIS
- SUMMARY
- 44. Bronchiectasis and Chronic Suppurative Lung Disease
- INTRODUCTION
- BRONCHIECTASIS AND CHRONIC SUPPURATIVE LUNG DISEASE
- PROTRACTED BACTERIAL BRONCHITIS
- SUMMARY
- ACKNOWLEDGMENT
- Section 7. Diffuse Lung Disease
- 45. New Concepts in Children’s Interstitial and Diffuse Lung Disease
- CONCEPTS, TERMINOLOGY, AND CLASSIFICATION
- GENERAL DIAGNOSTIC APPROACH
- TREATMENT
- RESOURCES FOR FAMILIES AND PHYSICIANS
- 46. Rare and Newly Recognized Childhood Lung Disorders
- INTRODUCTION
- PULMONARY ALVEOLAR MICROLITHIASIS
- ATAXIA TELANGIECTASIA
- GAUCHER DISEASE
- NIEMANN-PICK DISEASE
- NEUROFIBROMATOSIS
- DYSKERATOSIS CONGENITA
- HERMANSKY-PUDLAK SYNDROME
- LUNG DISEASE IN TBX4 GENETIC VARIANTS
- SUMMARY
- 47. Childhood Interstitial Lung Disease More Prevalent in Infancy
- OVERVIEW
- Developmental Lung Disorders
- ALVEOLAR GROWTH ABNORMALITIES PRESENTING AS CHILDHOOD INTERSTITIAL LUNG DISEASE
- PULMONARY INTERSTITIAL GLYCOGENOSIS
- NEUROENDOCRINE CELL HYPERPLASIA OF INFANCY
- SUMMARY
- 48. Lung Diseases Associated With Disruption of Pulmonary Surfactant Homeostasis
- OVERVIEW OF SURFACTANT COMPOSITION AND METABOLISM
- ETIOLOGY
- PATHOLOGY/PATHOGENESIS
- CLINICAL FEATURES OF SURFACTANT PRODUCTION DISORDERS
- DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS
- MANAGEMENT, TREATMENT, AND PROGNOSIS
- SUMMARY
- 49. Pulmonary Involvement in the Systemic Inflammatory Diseases of Childhood
- OVERVIEW OF CHAPTER
- JUVENILE IDIOPATHIC ARTHRITIS
- SYSTEMIC LUPUS ERYTHEMATOSUS
- JUVENILE DERMATOMYOSITIS
- SYSTEMIC SCLEROSIS (SCLERODERMA)
- MIXED CONNECTIVE TISSUE DISEASE
- SARCOIDOSIS
- CHILDHOOD VASCULITIDES
- GRANULOMATOSIS WITH POLYANGIITIS
- OTHER SYSTEMIC INFLAMMATORY DISEASES WITH SIGNIFICANT PULMONARY INVOLVEMENT
- CLINICAL APPROACH TO DIAGNOSIS AND MANAGEMENT OF PULMONARY INVOLVEMENT IN THE SYSTEMIC INFLAMMATORY DISEASES OF CHILDHOOD
- 50. Lung Injury Caused by Pharmacologic Agents
- CYTOTOXIC DRUGS USED IN CANCER THERAPY
- IMMUNOMODULATORY AGENTS USED IN CANCER THERAPY AND AFTER TRANSPLANTATION
- NONCYTOTOXIC DRUGS
- OTHER AGENTS
- CONCLUSIONS
- 51. Diffuse Alveolar Hemorrhage in Children
- ETIOLOGY OF DIFFUSE ALVEOLAR HEMORRHAGE
- TREATMENT OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
- ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE
- ISOLATED PULMONARY CAPILLARITIS
- COATOMER PROTEIN COMPLEX SUBUNIT ALPHA SYNDROME
- SAVI
- NONIMMUNE-MEDIATED ALVEOLAR HEMORRHAGE
- APPROACH TO THE CHILD WITH PULMONARY HEMORRHAGE
- SUMMARY
- 52. Hypersensitivity Pneumonitis and Eosinophilic Lung Diseases
- HYPERSENSITIVITY PNEUMONITIS
- LANGERHANS HISTIOCYTOSIS X (FORMERLY EOSINOPHILIC GRANULOMA)
- Section 8. Respiratory Complications in the Immunocompromised Child
- 53. Primary Immunodeficiency and Other Diseases With Immune Dysregulation
- DEFECTS OF THE INNATE IMMUNE SYSTEM
- DEFECTS OF THE ADAPTIVE IMMUNE SYSTEM
- 54. Pulmonary Disease in the Immunosuppressed Pediatric Patient
- INTRODUCTION
- PULMONARY INFECTIONS IN THE IMMUNOCOMPROMISED PEDIATRIC HOST
- CLINICAL PRESENTATION OF PULMONARY INFECTION IN THE IMMUNOCOMPROMISED CHILD
- INFECTIOUS RISKS SHARED BY MALIGNANCY, SOLID-ORGAN TRANSPLANTATION, AND STEM CELL TRANSPLANTATION
- COMMON PULMONARY INFECTIOUS AGENTS IN THE IMMUNOCOMPROMISED PEDIATRIC HOST
- RARER FUNGAL PNEUMONIAS
- NONINFECTIOUS PULMONARY COMPLICATIONS FOLLOWING SOLID-ORGAN TRANSPLANTATION (EXCLUDING THOSE UNIQUE TO LUNG TRANSPLANTATION)
- PULMONARY TOXICITY OF IMMUNOSUPPRESSIVE MEDICATIONS
- PULMONARY COMPLICATIONS OF CHILDHOOD TUMORS AND THEIR TREATMENT
- PULMONARY COMPLICATIONS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
- APPROACH TO PULMONARY DISEASE IN THE IMMUNOCOMPROMISED PEDIATRIC HOST
- NONINVASIVE DIAGNOSTIC STUDIES
- INVASIVE DIAGNOSTIC STUDIES
- PREVENTION STRATEGIES
- 55. Respiratory Disorders in Children and Adolescents Living With HIV
- SPECTRUM OF RESPIRATORY DISEASE
- ACUTE LUNG DISEASE
- CHRONIC LUNG DISEASE
- SUMMARY
- Section 9. Pulmonary Vascular Disease
- 56. Pulmonary Embolism and Thromboembolic Diseases
- EPIDEMIOLOGY
- ETIOLOGY
- CENTRAL VENOUS CATHETERS AND AGE-SPECIFIC ETIOLOGIES
- INHERITED AND ACQUIRED THROMBOPHILIA
- PATHOLOGY AND PATHOGENESIS OF PTE
- CLINICAL FEATURES
- IMAGING AND LABORATORY TESTS
- MANAGEMENT
- PREVENTION
- 57. Childhood Pulmonary Arterial Hypertension
- INTRODUCTION
- DEFINITION AND CLASSIFICATION
- EPIDEMIOLOGY AND ETIOLOGY
- NEONATAL PULMONARY HYPERTENSION
- ASSOCIATED PULMONARY ARTERIAL HYPERTENSION WITH CONGENITAL HEART DISEASE
- RISK STRATIFICATION
- MANAGEMENT
- ADDITIONAL PHARMACOTHERAPY: CARDIAC GLYCOSIDES, DIURETICS, ANTIARRHYTHMIC THERAPY, INOTROPIC AGENTS, AND NITRATES
- ATRIAL SEPTOSTOMY
- LUNG TRANSPLANTATION
- CONCLUSIONS
- 58. Pulmonary Arteriovenous Malformations
- INTRODUCTION
- GENETICS AND PATHOPHYSIOLOGY
- CLINICAL MANIFESTATIONS AND DIAGNOSTIC CRITERIA
- SCREENING AND TREATMENT
- SUMMARY
- 59. Pulmonary Lymphatic Disease
- Introduction
- Other Conditions
- Section 10. The Aerodigestive Model
- 60. The Aerodigestive Model: Improving Health Care for Complex Patients
- HISTORICAL PERSPECTIVES
- WHICH PATIENTS BENEFIT FROM AERODIGESTIVE CARE?
- ESTABLISHING A TEAM
- OUTCOMES AND RESEARCH
- SUMMARY
- 61. Aspiration, Feeding, and Swallowing Disorders
- INTRODUCTION
- EMBRYOLOGY/DEVELOPMENT OF THE UPPER AERODIGESTIVE TRACT
- ANATOMY, PHYSIOLOGY, AND DEVELOPMENT
- FEEDING SKILL DEVELOPMENT
- PHASES OF SWALLOWING
- EPIDEMIOLOGY OF PEDIATRIC FEEDING AND SWALLOWING DISORDERS
- ETIOLOGY/PATHOGENESIS
- CONDITIONS ASSOCIATED WITH FEEDING, SWALLOWING, AND AIRWAY PROTECTION PROBLEMS
- SPECIFIC AIRWAY CONDITIONS AND THE EFFECT ON FEEDING AND SWALLOWING
- EVALUATION OF FEEDING AND SWALLOWING
- DIAGNOSIS AND EVALUATION OF ASPIRATION
- ASPIRATION OF GASTROESOPHAGEAL REFLUX
- EVALUATION OF SALIVARY ASPIRATION
- LUNG INJURY DUE TO ASPIRATION
- BIOMARKERS OF ASPIRATION
- MULTIDISCIPLINARY APPROACH TO CHRONIC ASPIRATION
- TREATMENT STRATEGIES FOR FEEDING AND SWALLOWING DISORDERS
- TREATMENT CONSIDERATIONS FOR REFLUX ASPIRATION
- TREATMENT OF SALIVARY ASPIRATION
- AIRWAY SURGICAL INTERVENTIONS FOR ASPIRATION
- CONCLUSION
- 62. Gastroesophageal Reflux Disease and Eosinophilic Esophagitis in Children With Complex Airway Disease
- GASTROESOPHAGEAL REFLUX DISEASE
- DISORDERS OF MOTILITY
- EOSINOPHILIC ESOPHAGITIS
- 63. Laryngeal and Tracheal Airway Disorders
- INTRODUCTION
- OPERATIVE ASSESSMENT
- MITIGATING FACTORS
- OPTIMIZATION
- MANAGEMENT OF AIRWAY PATHOLOGY
- CONCLUSION
- Section 11. Disorders of Paediatric Sleep and Control of Breathing
- 64. Basic Physiological Principles of Sleep and Respiratory Control in Infants and Children
- NEURAL CIRCUITRY OF SLEEP AND WAKING
- MATURATION OF SLEEP CYCLES
- SLEEP AND BREATHING DURING DEVELOPMENT
- CENTRAL CHEMORECEPTORS AND THEIR DEVELOPMENT
- MULTIPLICITY OF CENTRAL CHEMOSENSITIVE CENTERS
- PERIPHERAL CHEMOREFLEXES
- 65. Testing for Sleep-Disordered Breathing
- INTRODUCTION
- PEDIATRIC SLEEP QUESTIONNAIRES
- PHYSICAL EXAMINATION
- DIAGNOSTIC SLEEP STUDY
- PHYSIOLOGIC ENDOTYPING
- ENDOSCOPY
- IMAGING APPROACHES
- BIOMARKERS
- SLEEP TECHNOLOGY
- CONCLUSION
- 66. Obstructive Sleep Apnea in Children
- INTRODUCTION
- EPIDEMIOLOGY
- OBSTRUCTIVE SLEEP APNEA–RELATED CARDIAC AND VASCULAR DYSFUNCTION
- 67. Complex Sleep and Hypoventilation Disorders in Children
- CENTRAL HYPOVENTILATION
- CONGENITAL CENTRAL HYPOVENTILATION SYNDROME
- ROHHAD SYNDROME
- OTHER HYPOVENTILATION DISORDERS
- CENTRAL SLEEP APNEA
- 68. Sudden Infant Death Syndrome, Brief Resolved Unexplained Events and Apparent Life-Threatening Events, and Apnea of Prematurity
- BRIEF RESOLVED UNEXPLAINED EVENTS AND APPARENT LIFE-THREATENING EVENTS
- APNEA IN PREMATURE INFANTS
- SUDDEN INFANT DEATH SYNDROME
- ACKNOWLEDGMENTS
- Section 12. The Critically Ill Child
- 69. Principles of Mechanical Ventilation
- HISTORY
- INDICATIONS FOR MECHANICAL VENTILATION
- APPLIED RESPIRATORY PHYSIOLOGY
- COMPOSITION OF A MECHANICAL VENTILATOR
- MODES OF VENTILATION
- HIGH-FREQUENCY VENTILATION
- NONINVASIVE VENTILATION
- SPECIAL CONSIDERATIONS OF MECHANICAL VENTILATION
- MONITORING
- COMPLICATIONS OF MECHANICAL VENTILATION
- WEANING AND EXTUBATION
- MECHANICAL VENTILATION IN SPECIFIC CONDITIONS
- CONCLUSION
- ACKNOWLEDGMENT
- 70. Pediatric Acute Respiratory Distress Syndrome
- DEFINITION AND DIAGNOSIS
- EPIDEMIOLOGY
- HISTOLOGY
- PATHOPHYSIOLOGY
- ETIOLOGY
- OUTCOMES: MORBIDITY AND MORTALITY, PREDICTORS OF OUTCOME, AND RISK STRATIFICATION
- MANAGEMENT
- SUMMARY/CONCLUSION
- 71. Pulmonary Edema
- ANATOMIC CONSIDERATIONS
- FACTORS RESPONSIBLE FOR FLUID MOVEMENT
- MECHANISMS THAT CAUSE PULMONARY EDEMA
- CLEARANCE OF PULMONARY EDEMA FLUID
- PATHOPHYSIOLOGIC CONSEQUENCES OF EDEMA
- CLINICAL PRESENTATION
- CLINICAL DISORDERS CAUSING PULMONARY EDEMA
- THERAPY
- 72. Lung Injury From Hydrocarbon Aspiration and Smoke Inhalation
- HYDROCARBON ASPIRATION
- RESPIRATORY COMPLICATIONS OF SMOKE INHALATION
- 73. Drowning
- DEFINITION
- PULMONARY INJURY
- NON-PULMONARY SEQUELAE
- MANAGEMENT
- OUTCOME OF PULMONARY INJURY
- OUTCOME PREDICTION OF NEUROLOGICAL INJURY
- PREVENTION
- 74. Trauma of the Thorax
- INTRODUCTION
- EPIDEMIOLOGY
- MECHANISMS OF INJURY
- PATHOPHYSIOLOGY
- PNEUMOTHORAX
- CARDIOVASCULAR INJURY
- INDICATIONS FOR SURGERY
- OUTCOMES
- PREVENTION
- SUMMARY
- 75. Respiratory Complications of Intensive Care
- HISTORY OF PEDIATRIC INTENSIVE CARE
- CONSIDERATIONS PRIOR TO INTUBATION AND MECHANICAL VENTILATION
- VENTILATION STRATEGIES
- COMPLICATIONS OF MECHANICAL VENTILATION
- CONCLUSION
- Section 13. Miscellaneous Pulmonary Disorders
- 76. Pulmonary Disease Associated With Congenital Heart Disease
- INTRODUCTION
- AIRWAY COMPRESSION DUE TO VASCULAR RINGS AND SLINGS
- Pulmonary Hypertension and Postoperative Pulmonary Hypertensive Crisis
- PULMONARY VEIN STENOSIS
- REPERFUSION PULMONARY EDEMA IN CHILDREN UNDERGOING PROCEDURES FOR TETRALOGY OF FALLOT, PULMONARY ATRESIA, AND MULTIPLE AORTOPULMONARY COLLATERAL ARTERIES
- Pulmonary Disease Associated With the Fontan Repair of Single Ventricle Physiology
- PULMONARY COMPLICATIONS RELATED TO CARDIAC SURGERY AND CARDIOPULMONARY BYPASS
- CONCLUSION
- 77. The Lung in Sickle Cell Disease
- EPIDEMIOLOGY
- ETIOLOGY
- PATHOGENESIS
- CLINICAL FEATURES
- DIAGNOSIS
- MANAGEMENT
- PREVENTION
- PROGNOSIS
- SUMMARY
- 78. Respiratory Complications of Down Syndrome and Other Genetic Syndromes
- INTRODUCTION
- UPPER AND LOWER AIRWAY DISEASE
- LUNG PARENCHYMAL DISEASE
- SLEEP-RELATED BREATHING DISORDERS
- CARDIORESPIRATORY INTERACTIONS AND PULMONARY VASCULATURE
- AERODIGESTIVE DISORDERS IN DOWN SYNDROME
- OBESITY AND ITS IMPACT ON THE LUNG IN DOWN SYNDROME
- THE APPROACH TO ORGANIZING CARE OF AND TREATING RESPIRATORY COMPLICATIONS OF DOWN SYNDROME
- COVID-19 IN CHILDREN WITH DOWN SYNDROME
- CONCLUSIONS
- OTHER GENETIC ANOMALIES
- 79. Tumors of the Chest
- EPIDEMIOLOGY
- ETIOLOGY
- BENIGN PRIMARY PULMONARY LESIONS
- MALIGNANT PRIMARY PULMONARY LESIONS
- CHEST WALL TUMORS
- MEDIASTINAL TUMORS
- PRIMARY CARDIAC AND PERICARDIAL TUMORS
- TUMORS OF THE DIAPHRAGM
- GENERAL APPROACH TO EVALUATION OF CHILDREN WITH SUSPECTED TUMORS OF THE CHEST
- MANAGEMENT AND TREATMENT OF THORACIC TUMORS
- ACKNOWLEDGMENTS
- 80. Respiratory Aspects of Neuromuscular Disorders
- INTRODUCTION
- PHYSIOLOGY
- ASSESSMENT AND MONITORING
- RESPIRATORY INTERVENTIONS
- COMPLICATIONS
- DISEASE MODIFYING TREATMENTS
- END OF LIFE MANAGEMENT
- SUMMARY
- 81. Air and Fluid in the Pleural Space, and Atelectasis
- INTRODUCTION
- EMBRYOLOGY AND ANATOMY
- PHYSIOLOGY
- AIR IN THE PLEURAL SPACE: PNEUMOTHORAX
- FLUID IN THE PLEURAL SPACE
- ATELECTASIS
- CONCLUSION
- Section 14. Emerging Threats to Children’s Lung Health
- 82. Environmental Contributions to Respiratory Disease in Children
- WHAT HAS CHANGED SINCE THE 9TH EDITION?
- VULNERABILITY OF CHILDREN TO ADVERSE ENVIRONMENTAL EXPOSURES
- What Can Be Done to Reduce Environmental Impacts on Respiratory Disease?
- Environmental Contributions to Acute Respiratory Illness and Pneumonia
- Environmental Contributions to Asthma
- Environmental Contributions to Cystic Fibrosis
- Impact of Climate and Environmental Change on Increased Risk of Respiratory Disease
- Summary
- 83. Combustible and Electronic Cigarettes: Tobacco and Marijuana Use in Children and Adolescents
- INTRODUCTION
- TOBACCO AND NICOTINE USE IN YOUTHS
- MARIJUANA USE IN YOUTHS
- ELECTRONIC NICOTINE DELIVERY SYSTEMS
- TREATMENT OF TOBACCO AND NICOTINE DEPENDENCE
- PROMOTION AND PREVENTION OF TOBACCO USE
- SUMMARY
- INDEX
- No. of pages: 1216
- Language: English
- Edition: 10
- Published: August 21, 2023
- Imprint: Elsevier
- Hardback ISBN: 9780323829151
- eBook ISBN: 9780323829168
AB
Andrew Bush
RD
Robin R Deterding
AL
Albert Li
FR
Felix Ratjen
PS
Peter Sly
HZ
Heather Zar
RW